HealthApr 1, 2026FDA approves Foundayo (orforglipron), Eli Lilly’s once-daily oral obesity medicationThe Food and Drug Administration has approved Foundayo, a once-daily oral obesity medication from Eli Lilly whose active ingredient is orforglipron, a non-peptide sm...FoundayoOrforglipron (small-molecule GLP-1 agonist)Wegovy+1
